These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9636615)

  • 21. Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation--successful treatment with plasma exchange.
    Dzik WH; Georgi BA; Khettry U; Jenkins RL
    Transplantation; 1987 Oct; 44(4):570-2. PubMed ID: 3313845
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange.
    Yango A; Morrissey P; Monaco A; Butera J; Gohh RY
    Clin Nephrol; 2002 Jul; 58(1):77-8. PubMed ID: 12141412
    [No Abstract]   [Full Text] [Related]  

  • 23. Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation.
    Zuckermann A; Birsan T; Thaghavi S; Kupilik N; Deviatko E; Dekan G; Wolner E; Klepetko W
    Transplant Proc; 1999; 31(1-2):1160-1. PubMed ID: 10083518
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease].
    Hirabayashi N
    Rinsho Ketsueki; 2000 Jun; 41(6):491-5. PubMed ID: 10921348
    [No Abstract]   [Full Text] [Related]  

  • 25. Radical reduction of smooth muscle cells in explanted lung of a LAM patient treated with sirolimus: first case report.
    Montero MA; Roman A; Berastegui C
    J Heart Lung Transplant; 2012 Apr; 31(4):439-40. PubMed ID: 22266380
    [No Abstract]   [Full Text] [Related]  

  • 26. Ticlopidine-induced thrombotic thrombocytopenic purpura.
    Muszkat M; Shapira MY; Sviri S; Linton DM; Caraco Y
    Pharmacotherapy; 1998; 18(6):1352-5. PubMed ID: 9855338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and efficacy of Neoral in heart transplantation.
    Yonan NA; Aziz T; el-Gamel A; Campbell CS; Rahman AN; Deiraniya AK
    Transplant Proc; 1998 Aug; 30(5):1906-9. PubMed ID: 9723328
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombotic thrombocytopenic purpura: a hematological emergency.
    Kessler CS; Khan BA; Lai-Miller K
    J Emerg Med; 2012 Sep; 43(3):538-44. PubMed ID: 22445678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases.
    Bennett CL; Weinberg PD; Rozenberg-Ben-Dror K; Yarnold PR; Kwaan HC; Green D
    Ann Intern Med; 1998 Apr; 128(7):541-4. PubMed ID: 9518398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
    Paquette RL; Tran L; Landaw EM
    Bone Marrow Transplant; 1998 Aug; 22(4):351-7. PubMed ID: 9722070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura.
    Perrotta S; Amendola G; Locatelli F; Conte ML; Rossi F; d'Urzo G; Nobili B
    Br J Haematol; 2003 Apr; 121(1):143-7. PubMed ID: 12670345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment with cyclosporine of thrombotic thrombocytopenic purpura refractory to corticosteroids and plasma exchange.
    Honda K; Hidaka S; Kobayashi S
    Ther Apher Dial; 2011 Apr; 15(2):215-7. PubMed ID: 21426520
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine-related neurotoxicity in a patient after bilateral lung transplantation for cystic fibrosis.
    Lischke R; Simonek J; Stolz AJ; Schützner J; Belsan T; Marusic P; Pafko P
    Transplant Proc; 2004 Nov; 36(9):2837-9. PubMed ID: 15621163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura.
    Nosari A; Redaelli R; Caimi TM; Mostarda G; Morra E
    Am J Hematol; 2009 May; 84(5):313-4. PubMed ID: 19306354
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders.
    Emilia G; Messora C; Longo G; Bertesi M
    Br J Haematol; 1996 May; 93(2):341-4. PubMed ID: 8639426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirolimus for lymphangioleiomyomatosis lesions.
    Egan JJ; Remund KF; Corris P
    N Engl J Med; 2008 May; 358(18):1963-4; author reply 1964. PubMed ID: 18450609
    [No Abstract]   [Full Text] [Related]  

  • 37. Refractory thrombotic thrombocytopenic purpura treated with cyclosporine.
    Bachman WR; Brennan JK
    Am J Hematol; 1996 Jan; 51(1):93-4. PubMed ID: 8571946
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient.
    Falk JA; Cordova FC; Popescu A; Tatarian G; Criner GJ
    J Heart Lung Transplant; 2006 Jan; 25(1):140-3. PubMed ID: 16399546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine.
    Jhaveri KD; Scheuer A; Cohen J; Gordon B
    Transfus Apher Sci; 2009 Aug; 41(1):19-22. PubMed ID: 19520610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphangioleiomyomatosis: a rare indication for lung transplantation.
    Shitrit D; Izbicki G; Ben-Dov I; Kramer MR
    Isr Med Assoc J; 2003 Jul; 5(7):533. PubMed ID: 12901257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.